Omkar Speciality Chemicals Limited is currently navigating a transformative structural and financial overhaul. Following its admission into the **Corporate Insolvency Resolution Process (CIRP)** on **December 5, 2022**, the company is transitioning from a state of operational paralysis toward a restructured entity under a **Resolution Plan** approved by the **National Company Law Tribunal (NCLT)**, Mumbai Bench, on **July 31, 2025**. --- ### **The NCLT-Approved Resolution & Capital Restructuring** The company’s future is defined by a rigorous capital reorganization designed to wipe the slate clean for new investment. The strategy, dictated by the **Successful Resolution Applicant (SRA)**, involves the total extinguishment of legacy equity to make room for fresh capital. * **Equity Extinguishment:** In a move to reset the ownership structure, **100%** of existing equity shares held by both **Promoters** and **Public Shareholders** are to be cancelled. The **Record Date** for this extinguishment was fixed for **April 29, 2026**. * **New Share Issuance:** Following the cancellation of old shares (face value **INR 10**), the company will issue **50,00,000** new equity shares at **INR 10** each. * **Incoming Controlling Entity:** These new shares are being issued via private placement to **IFFAS Kshitij SPV LLP**, which will become the primary stakeholder. * **Capital Infusion Breakdown:** * **Equity Consideration:** **INR 5,00,00,000** (Five Crores) from the issuance of new shares. * **Debt Funding:** Approval has been granted to raise up to **INR 20,00,00,000** (Twenty Crores) via a loan from **Kshitij Polyline Limited**. * **Total Resolution Package:** The integrated funding package totals **INR 21.9 Crore**, aimed at settling liabilities and providing a baseline for operational restart. --- ### **Governance Transition & Management Reconstitution** As the company exits the control of the **Resolution Professional (RP)** and the **Committee of Creditors (CoC)**, a new governance framework is being established to restore regulatory standing and operational oversight. * **Monitoring Committee Oversight:** During the transition phase, a **Monitoring Committee** is supervising the implementation of the Resolution Plan and finalizing the "future line of action" for business operations. * **Key Managerial Personnel (KMP) Appointments:** In **April 2026**, the company initiated the restoration of its leadership hierarchy by appointing a new **Chief Financial Officer (CFO)** and a **Whole-time Company Secretary & Compliance Officer**. * **Compliance Restoration:** A systematic effort is underway to rectify the backlog of statutory and contractual filings that were delayed or neglected during the **CIRP** period. * **Asset Identification:** The company has engaged **Kantikars Advisory LLP**, a specialized agency, to investigate and identify immovable properties and unencumbered assets that may not have been previously disclosed or properly accounted for in the company’s books. --- ### **Current Operational Constraints & Liquidity Crisis** Despite the approval of the Resolution Plan, the company’s immediate operational state remains fragile, characterized by a severe lack of internal resources. * **Acute Liquidity Shortage:** The entity has faced a near-total depletion of working capital. As recently as **August 2023**, the company was unable to fund even nominal expenses, such as the **INR 2 lakhs** required to procure raw materials for existing purchase orders. * **Dependency on Suspended Management:** Due to the lack of corporate funds, manufacturing activities have historically relied on the **Suspended Board of Directors (SBOD)** offering to personally bear manufacturing costs to fulfill orders. * **Verification and Counterparty Risks:** The company’s revenue pipeline has faced credibility challenges. Out of five purchase orders presented by the SBOD in mid-2023, **60% (3 orders)** could not be pursued because the **Resolution Professional** was unable to verify the existence of the counterparties via phone or email. * **Decision-Making Bottlenecks:** Until the Resolution Plan is fully executed, all major operational decisions remain subject to **CoC deliberation** and voting, which can lead to significant delays in responding to market opportunities. --- ### **Risk Profile & Comparative Status** Investors must weigh the potential of the restructured entity against the significant risks inherent in an insolvency turnaround. | Risk Category | Current Status / Impact | | :--- | :--- | | **Legal Status** | Transitioning from **CIRP** to **Resolution Plan Implementation** | | **Equity Value** | **Zero** for legacy shareholders; **100% extinguishment** mandated | | **Working Capital** | Historically **Negative/Nil**; dependent on **INR 20 Cr** loan infusion | | **Revenue Pipeline** | High uncertainty; previous orders showed **60%** unreachability rate | | **Management Control** | Shifting from **RP/CoC** to **Monitoring Committee** and **SRA** | | **Asset Integrity** | Ongoing investigation into **undisclosed/unencumbered assets** | --- ### **Strategic Roadmap & Growth Outlook** The immediate growth strategy is not focused on market expansion, but on **stabilization and handover**. The company’s trajectory is divided into three distinct phases: 1. **The Cleanse (Current):** Finalizing the cancellation of old equity and the formal issuance of new shares to **IFFAS Kshitij SPV LLP**. 2. **Debt Restructuring:** Utilizing the **INR 21.9 Crore** package to settle priority claims and treat prior earnest money deposits from the SRA as debt to streamline the balance sheet. 3. **Operational Scaling:** Once the handover is complete, the new management intends to leverage the **INR 20 Crore** loan from **Kshitij Polyline Limited** to restart manufacturing without relying on the personal funds of former directors. The long-term viability of Omkar Speciality Chemicals Limited depends entirely on the **Successful Resolution Applicant's** ability to convert the newly infused capital into a functional supply chain and verifiable customer contracts, moving beyond the "acute shortage" phase that defined its insolvency.